What is Vertex Pharmaceuticals's cost?

Vertex Pharmaceuticals (VRTX) reported cost of $25.00M in Q1 2026.

The original cost of equity investments whose value changes are recorded in net income.

Cost

Vertex Pharmaceuticals Cost remained flat by 0.0% to $25.00M in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ4 2025

Last reportedQ1 2026

Reflects the scale of equity market exposure and the company's appetite for market-linked investment returns.

The cost basis of equity securities measured at fair value through net income. This captures the initial investment valu...

Common in insurance companies with diversified investment strategies.

Metric ID: other_equity_securities_fv_ni_cost

2 periods

	Q4 '25	Q1 '26
Value	$25.00M	$25.00M
QoQ Change	—	+0.0%

Range$25.00M – $25.00M

What is Vertex Pharmaceuticals's cost?: Vertex Pharmaceuticals (VRTX) reported cost of $25.00M in Q1 2026.
What does cost mean?: The original cost of equity investments whose value changes are recorded in net income.